IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: FORMULATION AND CHARACTERIZATION OF EUDRAGIT RS 100 NANOSUSPENSION FOR OCULAR DELIVERY OF INDOMETHACIN
Authors Name: SRASHTI KATIYAR , Dr. PANKAJ MISHRA , JEEVAN CHANDRA PANDEY
Download E-Certificate: Download
Author Reg. ID:
IJNRD_181592
Published Paper Id: IJNRD2205180
Published In: Volume 7 Issue 5, May-2022
DOI:
Abstract: ABSTRACT Several colloidal drug delivery systems were designed to obtain a control release for ophthalmic applications were investigated. These are composed of a polymeric support with or without drug. The drug was normally incorporated as a dispersion or solution in the polymeric support. The main objective of the nano suspension is to increase the contact time of the preparation with conjunctiva tissues so as to ensure a Sustained / Controlled release suited for the topical or systemic treatment. However the details about the preparations and their model of construction are given in many literatures but no specific guideline are mentioned. In the present work, a revival attempts has made us to investigate Indomethacin ocular nano suspension utilizing Eudragit RS 100 as drug reservoir membrane and rate controlling component and its possible utilization in designing and evaluating it for ophthalmic use. All formulations were subjected to various evaluation parameters like identification and compatibility studies of drug and polymer using IR spectrometer and were evaluated for parameters like pH, particle size analysis, drug entrapment efficiency, rheological studies; rabbit eye irritation, in vitro release studies, in vivo drug studies and stability studies. The uniformity of the nano suspension revealed that the drug was uniformly distributed throughout the nano suspension. Increase in the polymer ratio increases the entrapment efficiency of drug which observed by entrapment efficiency studies. Further future work can be progressed to establish the therapeutic utility of these systems by pharmacokinetic and pharmacodynamic studies in human beings. The different Novel Technology can be adopted in the formulation for ophthalmic nano suspensions and thereby investigate their effect on release pattern.
Keywords: Introduction, Drug Profile, Experimental Investigation, Drug and Polymer Profile, Summary.
Cite Article: "FORMULATION AND CHARACTERIZATION OF EUDRAGIT RS 100 NANOSUSPENSION FOR OCULAR DELIVERY OF INDOMETHACIN ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 5, page no.1340-1352, May-2022, Available :http://www.ijnrd.org/papers/IJNRD2205180.pdf
Downloads: 000118746
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2205180
Registration ID: 181592
Published In: Volume 7 Issue 5, May-2022
DOI (Digital Object Identifier):
Page No: 1340-1352
Country: Bareilly, UTTAR PRADESH, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2205180
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2205180
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD